• Why CMO and supplier network collaboration is becoming a core capability for pharma companies that need more agility, resilience, and better decision-making across complex external networks.
• How stronger collaboration with suppliers can reduce risk, improve visibility, support faster launches, and ultimately improve patient outcomes.
• What a mature collaboration model looks like in practice, including the shift from basic data connectivity to broader multi-tier visibility and more coordinated planning and execution.
• The Bluecrux framework for getting there, built around four elements: transformation approach, supplier change management and rollout, capability development and deployment, and a center of excellence, plus a rapid way to assess gaps and opportunities.